Excision BioTherapeutics

Excision BioTherapeutics is a clinical-stage biotechnology company developing CRISPR-based gene-editing therapies intended to functionally cure serious viral infectious diseases. Its programs use multiplexed CRISPR/Cas approaches delivered via adeno-associated virus (AAV) to excise latent viral DNA from infected cells, with a lead candidate (EBT-101) targeting HIV and additional research directed at herpesviruses and hepatitis B. The company was surfaced as a portfolio company of Battery Ventures and added to the API Evangelist network. As a therapeutics company it does not currently publish a public developer API, SDK, or documentation surface; this profile therefore carries company identity and domain-security posture rather than API artifacts.

Excision BioTherapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Gene Editing, CRISPR, and Therapeutics.

🌐 Visit website 📡 Source on GitHub
7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyGene EditingCRISPRTherapeuticsInfectious DiseaseLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/excision-biotherapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Excision Biotherapeutics Domain Security

no transport/DNS hardening detected

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: excision-biotherapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/excision-biotherapeutics.png
name: Excision BioTherapeutics
description: Excision BioTherapeutics is a clinical-stage biotechnology company developing CRISPR-based gene-editing therapies
  intended to functionally cure serious viral infectious diseases. Its programs use multiplexed CRISPR/Cas approaches delivered
  via adeno-associated virus (AAV) to excise latent viral DNA from infected cells, with a lead candidate (EBT-101) targeting
  HIV and additional research directed at herpesviruses and hepatitis B. The company was surfaced as a portfolio company of
  Battery Ventures and added to the API Evangelist network. As a therapeutics company it does not currently publish a public
  developer API, SDK, or documentation surface; this profile therefore carries company identity and domain-security posture
  rather than API artifacts.
url: https://raw.githubusercontent.com/api-evangelist/excision-biotherapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- battery-ventures
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Gene Editing
- CRISPR
- Therapeutics
- Infectious Disease
- Life Sciences
apis: []
common:
- type: DomainSecurity
  url: security/excision-biotherapeutics-domain-security.yml
- type: Website
  url: https://www.excision.bio
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence